SBIO Among Health Care ETFs
End-of-day Nov 19, 2026 · 33 Health care ETFs by YTD
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | −0.7% | −6.0% | −3.7% | −24.0% | +2.6% | +12.2% | +116.1% | +17.6% | +134.9% | +129.7% |
| Peer average | −1.5% | −5.1% | −2.8% | −5.1% | +15.0% | +19.1% | +61.3% | +21.3% | +153.6% | — |
| S&P 500 · VOO | −2.0% | −5.5% | −7.4% | −6.3% | +5.8% | +9.7% | +65.8% | +65.5% | +290.0% | — |
$49 of every $1,000 in SBIO is CG
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | CGONCG oncology | Healthcare | 4.89% | $488.88 | 108K | $8.7M |
| 2 | ORKAOruka Therapeutics | Healthcare | 4.37% | $437.33 | 81K | $7.8M |
| 3 | MANEVeraDermics | Healthcare | 3.60% | $360.24 | 51K | $6.4M |
| 4 | TVTXTravere Therapeutics | Healthcare | 3.26% | $326.21 | 115K | $5.8M |
| 5 | DNTHDianthus Therapeutics | Healthcare | 3.24% | $324.27 | 68K | $5.7M |
| 6 | EWTXEdgewise Therapeutics | Healthcare | 3.10% | $309.75 | 133K | $5.5M |
| 7 | DFTXDefinium Therapeutics | Healthcare | 2.70% | $269.69 | 164K | $4.8M |
| 8 | XENEXenon Pharmaceuticals | Healthcare | 2.52% | $252.43 | 119K | $4.5M |
| 9 | SLSSELLAS Life Sciences Group | Healthcare | 2.50% | $250.32 | 247K | $4.4M |
| 10 | RLAYRelay Therapeutics | Healthcare | 2.50% | $249.84 | 268K | $4.4M |
| 11 | VRDNViridian Therapeutics | Healthcare | 2.36% | $235.61 | 139K | $4.2M |
| 12 | AMLXAmylyx Pharmaceuticals | Healthcare | 2.31% | $230.76 | 154K | $4.1M |
| 13 | TARSTarsus Pharmaceuticals | Healthcare | 2.30% | $230.11 | 54K | $4.1M |
| 14 | ACADACADIA Pharmaceuticals | Healthcare | 2.12% | $211.68 | 210K | $3.8M |
| 15 | VCELVericel | Healthcare | 2.07% | $207.44 | 63K | $3.7M |
of the $110B in 39 Health care ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | CGON | CG oncology | 4.89% |
| 2 | ORKA | Oruka Therapeutics | 4.37% |
| 3 | MANE | VeraDermics | 3.60% |
| 4 | TVTX | Travere Therapeutics | 3.26% |
| 5 | DNTH | Dianthus Therapeutics | 3.24% |
| 6 | EWTX | Edgewise Therapeutics | 3.10% |
| 7 | DFTX | Definium Therapeutics | 2.70% |
| 8 | XENE | Xenon Pharmaceuticals | 2.52% |
| 9 | SLS | SELLAS Life Sciences Group | 2.50% |
| 10 | RLAY | Relay Therapeutics | 2.50% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Dec 19, 2024 | Dec 26, 2024 | $1.17 |
| Dec 21, 2023 | Dec 27, 2023 | $0.0711 |
| Dec 19, 2019 | Dec 27, 2019 | $0.0160 |
| Dec 20, 2018 | Dec 27, 2018 | $0.78 |
| Dec 21, 2017 | Dec 28, 2017 | $0.58 |